| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.09 | 0.09 |